Josh Distler and Victoria Niklas (Oak Hill Bio)
Takeda spins PhII rare disease programs into new startup — sending 2 execs and some cash to get things going
The club of biotech startups developing programs spun out from Takeda keeps admitting new members.
Oak Hill Bio is the latest to debut, launching not …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
